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We constructed full-length cDNA clones of Sindbis virus that can be transcribed in vitro by SP6 RNA
polymerase to produce infectious genome-length transcripts. Viruses produced from in vitro transcripts are
identical to Sindbis virus and show strain-specific phenotypes reflecting the source of RNA used for cDNA
synthesis. The cDNA clones were used to confirm the mapping of the causal mutation of ts2 to the capsid
protein. A general strategy for mapping Sindbis virus mutations is described and was used to identify two lethal
mutations in an original full-length construct which did not produce infectious transcripts. An XbaI linker was
inserted in the cDNA clone near the transcriptional start of the subgenomic mRNA; the resulting virus retains
the XbaI recognition sequence, thus providing formal evidence that viruses are derived from in vitro transcripts
of cDNA clones. The potential applications of the cDNA clones are discussed.
Sindbis virus is the type species of the Alphavirus genus.
It is among the least pathogenic of the alphaviruses, a group
that includes such important pathogens as Venezuelan,
Western, and Eastern equine encephalitis viruses (25). In
nature, Sindbis virus is transmitted by mosquitos, and its
alternate vertebrate host is usually a bird or a mammal (80).
In vitro, Sindbis virus infects a variety of avian, mammalian,
reptilian (12), and amphibian cells (40). It also infects many
species of mosquitos, a tick (80), and Drosophila mela-
nogaster (6). Infection of vertebrate cells in culture is usually
characterized by a dramatic cytopathic effect and rapid cell
death, whereas growth in mosquito cells often leads to the
establishment of chronic or persistent infections.
Since its isolation in 1952 (80), Sindbis virus and the
closely related Semliki Forest virus have been widely stud-
ied (for a review, see reference 69). The genome of Sindbis
virus consists of a single molecule of single-stranded RNA,
11,703 nucleotides (nt) in length (74, 76). The genomic RNA
is infectious, is capped at the 5' terminus and polyadenylated
at the 3' terminus, and serves as mRNA and is therefore by
convention of plus polarity. During infection of vertebrate
cells, the virus attaches to the cell surface and is endo-
cytosed. Acidification of the endocytic vesicle activates the
viral envelope proteins to mediate fusion of the viral enve-
lope with the vesicle wall, thus depositing the genome in the
cytoplasm (31). The 5' two-thirds of the genomic 49S RNA is
translated during early infection to produce two polyproteins
that are processed by cotranslational or posttranslational
cleavage into four nonstructural proteins (called nsPl
through nsP4, numbered in order as they appear in the
genome sequence; 74) presumably required for RNA repli-
cation. A full-length minus strand complementary to the
genomic RNA is first synthesized; this minus strand then
serves as a template for the synthesis of new 49S genomic
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RNA molecules. The three structural proteins are encoded
in the 3' one-third of the genome. They are expressed by
transcription of the minus strand at an internal site to
produce a 26S subgenomic mRNA that is 4,106 nt long and
colinear with the 3'-terminal one-third of the 49S genome.
The subgenomic mRNA is capped and polyadenylated. It
does not serve as a template for minus-strand synthesis, nor
is it packaged into mature virions. Translation of the 26S
mRNA produces a polyprotein that is cleaved cotranslation-
ally by a combination of viral and presumably host-encoded
proteases to give the capsid protein (C) and the two envelope
glycoproteins (El and PE2, the precursors of the virion E2).
The translation, proteolytic cleavage, glycosylation, fatty
acid attachment, and transport of these proteins have been
extensively studied both in vivo and in vitro as models for
membrane protein biogenesis (for a review, see reference
68). The capsid protein complexes with the 49S genomic
RNA to form intracellular icosahedral nucleocapsids, which
interact with the cytoplasmic domains of the transmembrane
envelope proteins at the cell surface, resulting in the budding
of virus from the plasma membrane (23). The virus thus
acquires a lipid envelope derived from the host cell. The
proteins and RNA in mature virions are exclusively virus
encoded.
Genetic analysis of Sindbis virus has been facilitated by
the isolation of ts mutants defective in RNA replication
(RNA- mutants) and in the production of the structural
proteins (RNA' mutants). These mutants have been
grouped by complementation into three RNA+ and four
RNA- groups (8-10, 65, 67, 73, 75). Representative mutant-
revertant pairs from RNA+ groups C, D, and E have been
analyzed by sequence analysis, and there is excellent corre-
lation between specific sequence changes and phenotypes (2,
27, 44). None of the RNA- defects has been rigorously
assigned to specific nonstructural proteins or RNA se-
quences.
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Over the past several years, recombinant DNA technol-
ogy has profoundly advanced the study of RNA viruses.
Sequence analysis of cDNA clones of RNA viruses contrib-
uted to the identification of potential translation products
and, by sequence comparison, of conserved, potentially
cis-acting sequences implicated in replication and gene
expression. However, rigorous tests of these conclusions
require the manipulation and expression of functional viral
genomes. This has led to the construction ofcDNA copies of
the bacteriophage Qp (79) and poliovirus (55, 60, 70) which,
after transfection of the appropriate host cells, produce
infectious transcripts in vivo. Subsequently, a number of
laboratories have succeeded in producing infectious tran-
scripts synthesized in vitro from cDNA clones for several
plant viruses (1, 13, 14, 18, 24, 50, 71, 77, 82) and animal
viruses (16, 30, 52, 81). Using the same approach, we
previously reported the deletion mapping of the cis-acting
sequences required for the replication and encapsidation of
defective-interfering genomes of Sindbis virus (43). We
describe here the construction of cDNA clones of Sindbis
virus capable of producing infectious transcripts in vitro. We
also demonstrate the use of these clones for mapping the
causal lesions for mutants with interesting phenotypes and
for site-directed mutagenesis to construct novel mutants of
Sindbis virus.
MATERIALS AND METHODS
Virus stocks, growth, and purification. Sindbis virus stocks
derived from the cDNA clones described below, as well as
the HR small plaque strain (HRsp, stock no. 80-5724; 74);
temperature-sensitive (ts) mutants ts2, ts6, tsll, tsl8, and
ts24; and an HR large plaque strain (HR; S. Schlesinger
laboratory strain; 8, 9) were grown on monolayers of pri-
mary or secondary chicken embryo fibroblasts (CEF) and
titers were determined as previously described (73). The ts
mutants were plaque purified for use in complementation
analyses. The virus was purified by polyethylene glycol
precipitation from the culture media, followed by successive
velocity sedimentation and equilibrium density centrifuga-
tions (58). The isolation of intracellular (43, 57, 84) and virion
RNA (4, 58, 62) was as described.
General recombinant DNA techniques. Restriction endo-
nucleases and DNA modifying enzymes were purchased
from commercial sources and used essentially as recom-
mended by the manufacturer. Plasmids were grown, puri-
fied, and analyzed by standard methods with minor modifi-
cations (47).
cDNA synthesis, purification, and primer extension. cDNA
synthesis and cloning of Sindbis virion RNA from purified
virus have been described (62, 74). Double-stranded cDNA
restriction fragments used to construct derivatives of TotoS
(see below) were purified by extraction from preparative
low-melting-temperature agarose gels (83). For sequence
analysis of RNA prepared from TotolOOO- and Totol0O2-
infected CEF cells, a 5'-end-labeled oligonucleotide (com-
plementary to nt 7644 through nt 7662 of the Sindbis virus
genome; 74) was annealed to total cytoplasmic RNA and
extended with avian myeloblastosis virus reverse trans-
criptase (15). Discrete extension products corresponding to
the 5' end of 26S RNA were isolated from a preparative
sequencing gel and sequenced by the chemical method (48).
Construction of full-length Sindbis cDNA clones. An origi-
nal full-length cDNA clone of Sindbis virus HRsp, called
Totol (Fig. 1), was reconstructed from the four HindIII
subclones of the Sindbis virus genome used for determina-
tion of the sequence (74). The HindIII cDNA fragments were
subcloned into Proteusl. Proteusl consists of the replicon
and the beta-lactamase gene of pBR322, from the ThaI
(position 2522) to EcoRI (position 1) sites, with the ThaI end
fused to the filled-in BglII end of a BgIII-ClaI fragment from
SP6 phage containing a SP6 RNA polymerase promoter (E.
Butler and P. Little, unpublished data.) The same promoter
was subsequently used to construct pSP64 (49). A polylinker
sequence (5'-AAGCTTCTAGAGATCTGCAGGTCGAC
GGATCCCCGGGAATTCCGCGGAATT-3') was posi-
tioned between the Clal site from SP6 phage and the filled-in
EcoRI site from pBR322.
The 5' terminus of Sindbis virus cDNA was fused to the
SmaI site in the polylinker of Proteusl (74). The GC tail at
the 5' terminus regenerated the SmaI site. The site was
converted to a Clal site by cutting with SmaI and ligating in
Clal linkers (pCATCGATG), and it was used to fuse the
Sindbis virus 5' terminus to the Clal site downstream of the
SP6 promoter. This 5' clone included the HindlIl site at
position 125 of Sindbis virus. The 3' terminus of Sindbis
virus cDNA was cloned as a Hindlll (position 6267) to the
poly(A)-poly(T) fragment between the Hindlll and SmaI
sites of Proteusl (74). The 5' and 3' clones were combined by
ligating at the respective HindIII sites. (The SstII site in the
polylinker was converted to a SstI site, by using SstI linkers,
for subsequent runoff transcription). The two internal
HindIII fragments (nt 125 to 1302 and 1302 to 6267) were
then inserted, in the correct order and orientation, in the
HindIII site of the 5'-3' clone to produce Totol. Totol has
198 nt between the SP6 transcription start and the 5' nucle-
otide of the Sindbis virus genome, including 9 G residues,
derived during cDNA cloning, immediately 5' to the Sind-
bis virus sequences. The 3'-terminal poly(A) tract consists
of ca. 35 residues followed by the sequence 5'-G
GGAATTCGAGCTC-3', the last six nucleotides of which
comprise the SstI site used for runoff transcription.
Toto2 was derived from Totol by inserting a ClaI linker
(pCATCGATG) into a HaeIII site in SP6-derived sequences,
cutting with ClaI, and ligating to the SP6-derived ClaI site
downstream of the SP6 promoter (see above). This left 48 nt
between the SP6 transcription start and the Sindbis virus 5'
nucleotide. Toto3 was derived from Toto2 by deleting all
SP6-derived sequences preceding the Sindbis virus se-
quences. We took advantage of an HphI recognition se-
quence in the SP6 promoter that directs HphI cutting after
the A 1 nt 3' from the G that corresponds to the major
transcriptional initiation site for SP6 RNA polymerase (un-
published observations; 29). We fused the HphI cut site (T4
DNA polymerase treated to remove the 3' protruding A) to
a SfaNI site (filled in by treatment with the large fragment of
DNA polymerase I) created by the HaeIII-ClaI linker fusion
in Toto2. Toto3 has eight extra G's preceding the Sindbis
virus sequences. Toto5, derived from Toto3, had all but one
extra G removed. The fragment from Toto3 containing the
SP6 promoter and the 5'-terminal 125 nt of Sindbis virus (to
a HindIII site at position 125) was first subcloned into ITAN8
(W. C. Hollifield et al., unpublished data). This clone, called
ITK1, has an unique RsaI site 14 nt downstream from the
Sindbis virus 5' terminus and an unique HphI recognition
sequence in the SP6 promoter (see above). A pair of com-
plementary synthetic oligonucleotides, corresponding to the
Sindbis virus 5' terminus through nt 14, was ligated to RsaI-
and HphI-digested and T4 DNA polymerase-treated ITK1.
The resulting clone, rrK2, was verified by sequence analysis,
and the SP6 promoter-Sindbis virus 5'-terminal sequences
were recloned into Toto3 to give Toto5.
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Toto2 = 48 nt ATTG
Toto3 r cG8ATTG
Toto5 G ATTG
Cla
TTTCA35 oGG AATTCGAGC C
TTTCA35 GGGAATTCCAGCTC
-TTTCA35 GGGAATTCGAGCTC
TTTCA35 GGGAATTCGAGCTC
Bss HIl
TotolOI GATTG TTTCA35 GGrAATTCGAGCTC
Cla I Spe I
Il
Toto50 GATTG TTTCA35GGGAATTCGAGCTC
Cla I Bss HIl Sst II
Tote 1000 <o G ATTG TTTCA35CGGAATTCGAGCTC
non-structural structural
nsP I nsP2 |nsP3 |nsP4 C IPE2 16K-E11
0 2 4 6 8 10 12 Kb
FIG. 1. Structure of full-length cDNA clones of Sindbis virus. The open arrow denotes the SP6 RNA polymerase promoter. Extraneous
sequences preceding the Sindbis virus sequences are indicated. The first and last four nucleotides of Sindbis are shown. All clones have a 3'
poly(A) tract ca. 35 nt long. The sequence between the poly(A) tract and the SstI site used for runoff transcription is shown. All clones
consisted of HRsp cDNA except the HR-derived sequences in TotolO and TotolOOO, indicated by filled-in bars extending from ClaI 2713 to
BssHII 9804. Totol000 contains an additional substitution from BssHII 9804 to SstII 11484 of HRsp cDNA (open bar). The open bar in Toto5O
indicates HRsp-derived sequences, from ClaI 2713 to SpeI 5262, from an independent HRsp cDNA clone. The coding regions of the viral
proteins are outlined at the bottom of the figure (nucleotide positions are indicated in kilobases). The plasmid beta-lactamase gene and replicon
are not shown.
A derivative of Toto5 was made by substituting the ClaI
(nt 2713) to SpeI (nt 5262) region of TotoS with that from an
independent subclone (of the HindlIl [nt 1302] to HindIII [nt
6267] region) of cDNA from Sindbis virus HRsp to produce
Toto5O. Similarly, the ClaI to SpeI fragment from Sindbis
virus HR cDNA was used to replace the corresponding
region of TotoS to give Toto5CS. The same ClaI to SpeI
fragment of Sindbis virus HRsp cDNA was used to replace
the corresponding region of Toto3 to give Toto30. The ClaI
(nt 2713) to AvrII (nt 4280) region of TotoS was replaced with
Sindbis virus HR cDNA from TotollO1 (see below) to give
Toto5CA. Subclones of Toto5 were made for smaller substi-
tutions between the ClaI and AvrII sites. Two fragments of
Toto5, from Hindlll (nt 1302) to BamHI (nt 4633) and from
BglII (nt 2288) to BamHI (nt 4633), were cloned in wrAN7
(46). Various regions of the two subclones were replaced
with corresponding regions from the HindIII subclone of
HRsp cDNA (see above). The ClaI (nt 2713) or BglII (nt
2288) to AvrII (nt 4280) fragment from the resulting clones
was then used to replace the corresponding region of TotoS
to produce the clones Toto5CP, Toto5CN, Toto5BN,
Toto5NT, Toto5PT, Toto5Bs, and Toto5TA (see Results and
Table 2).
The ClaI (nt 2713) to BssHII (nt 9804) interval of Toto5
was also replaced with the corresponding Sindbis virus HR
cDNA, transformants were screened for clones that pro-
duced infectious transcripts, and one such clone was called
TotolO. The BssHII (nt 9804) to SstII (nt 11484) interval of
TotolO was further replaced with Sindbis virus HRsp cDNA,
and transformants were screened for clones that gave infec-
tious transcripts, one of which was called TotolOOO. TotolO
and TotolOOO are therefore hybrids of Sindbis virus HRsp
and HR (Fig. 1).
A plasmid clone, called TrnsP4Cl, consisting of the AccI
(nt 7492) to NcoI (nt 8038) region of TotolOOO cloned in
-TrAN7, was digested with RsaI (nt 7611) and ligated in the
presence of 43 mM XbaI linker (pTCTAGA). After transfor-
mation, clones that contain the XbaI linker were selected by
digestion with XbaI, isolation of linear DNA, ligation, and
retransformation. A representative clone, TC1R, with a
single XbaI linker inserted at RsaI (nt 7611) was then
extended in the 5' direction by cloning in the HindIII (nt
6267) to AccI (nt 7492) interval from TotolOOO. The resulting
clone, rrnsP4CR, contains unique HpaI (nt 6919) and AatII
(nt 7999) sites, which were used to excise the XbaI linker-
containing fragment for replacement into TotolOOO to give
TotolO02.
XTotollO1, a lambda phage clone of a full-length copy of
the Sindbis virus genome downstream from the SP6 pro-
moter, was constructed from XgtWES-XB (41) by replacing
the SstI-XhoI region (A positions 25881 to 33498) with the
SstI to XhoI fragment of TotollO1 containing the SP6
Toto I C 198 nt ATTG
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promoter and the Sindbis virus genome (TotollOl is derived
from TotolOOO by replacing the 3' Sstl site used for runoff
transcription with a XhoI site).
Toto ts2.1 was constructed by replacing the Narl (nt 7870)
to MstII (nt 8892) region of TotolOOO with the corresponding
region from a cDNA clone ofts2 designatedts2A (this clone
was produced as described in reference 44 and contains the
ts2 RNA sequence from the HindIlI site at nt 6267 to the
poly(A) tail, and it was generously provided by C. S. Hahn).
The presence of the putative ts2 mutation (27) in the result-
ing clone was verified by chemical sequence analysis.
In vitro transcription and capping. RNA transcripts were
synthesized in vitro by SP6 RNA polymerase with either
supercoiled plasmid templates or plasmid DNAs digested
with appropriate restriction endonucleases for production of
runoff transcripts. Reactions containing 40 mM Tris chloride
(pH 7.6); 6 mM MgCl2; 2 mM spermidine; 1 mM each ATP,
CTP, UTP, and GTP; 100,ug of nuclease-free bovine serum
albumin per ml; 5 mM dithiothreitol; 500 U of human
placental RNase inhibitor per ml; 400 U of SP6 RNA
polymerase per ml; and 10 to 100,ug of template DNA per ml
were incubated at 38°C for 1 h (11, 36, 49). 5'-capped
transcripts were produced by inclusion of 1 mM
m7G(5')ppp(5')G or m7G(5')ppp(5')A cap analogs in the tran-
scription reaction (34). Trace quantities of 3H-UTP or [cx-
32P]CTP included in the transcription reactions allowed
quantitation and gel analysis of the RNA transcripts. Incor-
poration was measured either by trichloracetic acid precip-
itation or by adsorption to DE 81 filter paper (Whatman,
Inc., Clifton, N.J.) (47). Template DNAs did not need to be
purified by banding on CsCl gradients, and several protocols
for rapid plasmid and phage DNA preparation were satisfac-
tory, provided that the template DNA was RNase-free and
salt-free (11). Transcripts made from supercoiled plasmid
DNA from minipreps were infectious. However, their spe-
cific infectivities were variable, typically about 10-fold lower
than the transcripts produced by runoff transcription. RNA
products which comigrated with full-length runoff transcripts
were found when either uncut lambda or supercoiled plasmid
templates were used, and such products may result from the
falloff of the SP6 polymerase in the poly(A) tract or shortly
thereafter. For rapid assay of transcript infectivity or for
production of virus stocks, the transcription mix was used
directly for transfection (see below). For purified transcripts,
the template DNA was removed by digestion with DNase I,
followed by extraction with phenol-chloroform and ethanol
precipitation.
RNA transfection. Typically, confluent monolayers of sec-
ondary CEF in 35-mm tissue culture plates (about 106 cells)
were used for transfection. After washing once with Eagle
minimal essential medium with Earle salts (MEM) without
serum, the cells were incubated with 1.5 ml of MEM
containing 50 mM Tris chloride (pH 7.3) (at 25°C) and 200 ,ug
of DEAE dextran per ml (average molecular weight, 500
kilodaltons [kDa]; Sigma Chemical Co., St. Louis, Mo.) for
15 to 60 min at 37°C. This medium was removed and 200 ,ul
of RNA or transcription mix (diluted in phosphate-buffered
saline) was added to the cells and incubated at room tem-
perature for 15 to 60 min with occasional rocking. PFU were
quantitated by overlaying the monolayers with 2 ml of 1.2%
agarose (SeaKem; FMC Corp., Marine Colloids Div.,
Rockland, Maine) in MEM and 2% fetal calf serum followed
by incubation at 37°C for wild-type stocks or at 30 and 40°C
for ts mutants. Plaques were visualized by staining with
neutral red or crystal violet after 24 to 48 h (37 or 40°C
incubation) or 48 to 72 h (30°C incubation). For production of
virus stocks, the transfection mix was removed and the cells
were incubated with 2 ml of MEM containing 2% fetal calf
serum for 24 (37°C) or 48 h (30°C).
RNA gel analysis. Monolayers of secondary CEF cells
were infected with Sindbis virus stocks at a multiplicity of
infection of 20 PFU per cell. Virus-specific RNA was labeled
in the presence of MEM containing 1,ug of actinomycin D
per ml and 20,uCi of [3H]uridine per ml from 3 to 6 h
postinfection. Cytoplasmic RNA was isolated, denatured
with glyoxal and dimethylsulfoxide, and analyzed by elec-
trophoresis in 1% agarose gels (47).
Analysis of 5' and 3' termini of transcripts and virion RNAs.
For 5'-end analysis, in vitro transcripts were labeled by
transcription in the presence of [a-32P]ATP. Virion RNAs
were labeled in vivo with 32P04. Cells were infected with
Sindbis virus HRsp or virus derived from Toto5O and incu-
bated with phosphate-free MEM and 3% chicken serum. At
5 h postinfection, 100 pCi of 32P04 per ml was added, and the
infection was allowed to proceed for an additional 9 h. The
virus was purified, and the virion RNA was extracted (see
above). For 3'-end labeling, [5'-32P]pCp was first synthe-
sized with 3' CMP and crude [y-32P]ATP (7,000 Ci/mmol, 200
,uCi/,ul; ICN Pharmaceuticals Inc., Irvine, Calif.). The reac-
tion contained 3,ul of crude [-y-32P]ATP, 4.5 nmol of 3' CMP,
and 5 U of T4 kinase in a final volume of 5 ,ul and was
incubated for 6 h at 37°C, after which it was judged to be
essentially complete by ascending chromatography on poly-
ethyleneimine cellulose (developed in 2M sodium formate,
pH 3.5). Approximately 0.5 pmol of either virion RNA or in
vitro transcripts was 3'-end labeled with the crude [5'-
32P]pCp and T4 RNA ligase (21). The reactions contained 25
mM Tris chloride (pH 8.3), 7 mM MgCl2, 20 mM dithiothre-
itol, 1 mM ATP, 15% dimethyl sulfoxide, 70 mCi of [5'-
32P]pCp per ml, 1,000 U of T4 RNA ligase (Bethesda
Research Laboratories, Inc., Gaithersburg, Md.) per ml, and
200 jig of RNA per ml and were incubated at 4°C for 20 h.
The end-labeled RNAs were recovered by ethanol precipi-
tation after extraction with phenol and chloroform. The
labeled RNAs were further purified by two selections with
oligo(dT) cellulose (Pharmacia, Inc., Piscataway, N.J.) by
following the directions of the supplier. RNA samples con-
taining 10 p.g of carrier tRNA were digested with 1 U of
RNase T2 at 50°C for 1 h in 50 mM NH4OAc (pH 5.3). The
digestion products were spotted onto cellulose plates and
separated by two-dimensional thin-layer chromatography (34).
Protein analysis. For comparison of structural and
nonstructural proteins of parental virus strains and stocks
derived from infectious transcripts, secondary CEF cells
were infected at a multiplicity of infection of 20 to 50
PFU/cell. At 3 h postinfection, cells were labeled in methi-
onine-free media containing 20 ,uCi of L-[35S]methionine per
ml (ICN translabel) for 1 h. Proteins in ts2-infected cells or in
cells infected with virus derived from Totots2.1 were labeled
from 7 to 8 h (30°C) or 6 to 7 h (40°C) postinfection. Cell
extracts were prepared by washing the monolayers twice
with ice-cold phosphate-buffered saline and by lysis of the
monolayer with 0.5% sodium dodecyl sulfate containing 40
,ug of phenylmethylsulfonyl fluoride per ml. Samples were
electrophoresed on 10% discontinuous sodium dodecyl sul-
fate-polyacrylamide gels (37), treated for fluorography (39),
and exposed to X-ray film. Sindbis virus-specific structural
and nonstructural protein standards were prepared by im-
munoprecipitation (63) with monospecific polyclonal rabbit
antisera to each of the proteins (63); antisera to nsPl, nsP2,
nsP3, and nsP4 were generously provided by W. Reef
Hardy, California Institute of Technology, Pasadena.
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RESULTS
Infectious in vitro transcripts of Sindbis virus cDNA clones.
We constructed full-length cDNA copies of the Sindbis virus
RNA genome, positioned downstream from the SP6 RNA
polymerase promoter, such that transcripts have either 198
nt (Totol), 48 nt (Toto2), 8 G's (Toto3, Toto30), or a single
G (Toto5, TotolO, Toto5O, TotolOOO) preceding the Sindbis
virus-derived sequences (Fig. 1; Materials and Methods).
The clones may be linearized at a SstI site 3' of the poly(A)
sequences of Sindbis virus for runoff transcription in vitro.
Although a substantial proportion of the in vitro tran-
scripts derived from Totol, Toto2, Toto3, and Toto5 tem-
plate DNAs appeared to be full-length (e.g., Fig. 2) and
contained poly(A) (data not shown), they were not infec-
tious. Since Toto5 has only a single extra G at the 5'
terminus, we suspected that our inability to produce infec-
tious transcripts might be due to the presence of one or more
lethal mutations in the Sindbis virus cDNA clone. Since
Toto5 contains a number of unique restriction sites in the
Sindbis virus sequences, we used these sites to replace
defined intervals of the Sindbis insert of Toto5 with cDNA
derived from an independent HRsp cDNA clone. One of the
resulting clones is called Toto5O (Fig. 1). Similarly, TotolO
and TotolOOO contain large regions which have been re-
placed with cDNA derived from Sindbis virus strain HR. In
vitro runoff transcripts of TotolO, Toto5O, TotolOOO (Fig. 2),
and XTotol1O1 (see Materials and Methods) produce infec-
tive centers when transfected into CEF, suggesting that
Toto5 contains one or more lethal mutations in the replaced
regions (see below). Table 1 shows that the infective centers
must be derived from RNA transcripts of the cDNA clone,
since the DNA template is required only for the transcription
step and is dispensable after transcription, when infective
center formation becomes sensitive to RNase A. Under
these conditions, the DNA is not infectious. The cap analog,
m7G(5')ppp(5')G, was included during transcription so that
the resulting transcripts would contain a 5' cap (34). The
12 34 56
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FIG. 2. In vitro transcripts. RNAs isolated from the transcrip-
tion reactions described in Table 1 were denatured with glyoxal and
DMSO and electrophoresed on a 1% agarose gel. Lanes: 1 to 3,
transcription products made in the presence of m7G(5')ppp(5')A,
m7G(5')ppp(5')G, and no cap, respectively; 4, RNase A digestion
after transcription; 5, DNase I digestion after transcription; 6,
DNase I digestion before transcription. The markers are indicated
and correspond to Sindbis virion RNA (11.7 kb) and a 4.1-kb SP6
premature transcription product (present in minor amounts in lanes
1 to 3 and 5) which comigrates with Sindbis virus 26S RNA
(unpublished observation).
TABLE 1. Infectiousness of in vitro transcripts of TotolOOO
Conditionsa (PFURNAg)b
Complete [m7G(5')ppp(5')G] ..............................4.0 x 104
m7G(5')ppp(5')A.......................................... 1.1 x 104
No cap analog............................................ 1.3 x 102
DNase I before transcription ............................. oc
DNase I after transcription ............................... 1.0 x 104
RNase A after transcription ............ .................. 0
a Complete SP6 transcription reaction [including m7G(5')ppp(5')G; see
Materials and Methods] except for the modifications listed. Dilutions of the
transcription mixes were used directly for transfection.
I PFU produced per pLg of transcribed RNA. Titrations were done in the
range of 0.1 ng to 1 ,ug of RNA. Values of PFU/pig were extrapolated from
titrations in the range of 1 to 10 ng of RNA.
' Less than 1 PFU in the entire transcription reaction (the usual yield was
1 to 1.2 ,ug of transcripts when the template was not pretreated with DNase I).
specific transfectivity of the capped transcripts is about
10-fold less than that of 49S RNA (1 x 105 to 4 x 105
PFU/,Lg) extracted from Sindbis virions, even when the
fraction of apparently full-length transcripts was accounted
for. The lower specific infectivity of the in vitro transcripts
could be due to nonviral nucleotides at the termini of the
transcripts (see below) or the presence of incomplete, pre-
mature falloff products from transcription, despite the ob-
servation that some of the transcripts appear full length on
agarose gels.
Although the in vitro transcripts are expected to initiate
with G, we find little difference in the specific transfectiv-
ity of transcripts made in the presence of the cap ana-
logs m7G(5')ppp(5')G and m7G(5')ppp(5')A. The transcripts
made in the presence of m7G(5')ppp(5')G are indeed capped,
as demonstrated by analysis of the 5' ends (34) and by the
fact that the specific transfectivity of transcripts made in the
absence of cap analogs is 100-fold lower. Direct evidence for
incorporation of the m7G(5')ppp(5')A cap analog was not
obtained since the Gp spot obscured the m7G(5')ppp(5')Ap
spot in our two-dimensional separations. Additional nucleo-
tides at the 5' end of the transcripts seem to be deleterious,
since Toto30 transcripts, identical to Toto5O transcripts
except for having 8 extra G-'s at the 5' terminus, were not
infectious (<1 infectious center per p.g of RNA).
Properties of virus derived from transcripts of the cDNA
clones. Virus stocks derived from transfection with in vitro
transcripts have efficiencies of plating at 30, 37, and 40°C
that are indistinguishable from the parental Sindbis virus
strains. Toto5O, like its parental Sindbis virus HRsp strain,
gave small plaques. Plaque sizes of TotolO and TotolOOO,
which are hybrids of Sindbis virus HRsp and HR (Fig. 1),
were intermediate between those of Sindbis virus HRsp and
HR. Presumably, one or more determinant(s) affecting
plaque size maps in the ClaI (nt 2713) to BssHII (nt 9804)
interval (which encompasses most of nsP2 through to near
the end of E2).
RNA of virus derived from infectious transcripts. Both the
intracellular, virus-specific RNA species from transfected
cells and the virion RNAs of purified virus derived from in
vitro transcripts are indistinguishable from that of Sindbis
virus by gel electrophoresis after denaturation (results not
shown). Transfection efficiencies of virion RNAs of Toto-
derived stocks were comparable to 49S virion RNA of the
parental Sindbis virus.
We analyzed virion RNAs labeled in vivo with 32p, de-
rived from either HRsp or TotolOOO, by two-dimensional
chromatography after complete digestion with RNase T2.
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The patterns were indistinguishable. However, because of a
high background of unidentified nucleosides, neither
m7G(5')ppp(5')Ap, m7G(5')ppp(5')Gp, nor pppGp could be
unambiguously identified (data not shown). Thus, if tran-
scripts containing an extra G residue are infectious, it is
unknown whether this residue is eliminated in subsequent
amplification in vivo. The 3'-terminal nucleotides were ana-
lyzed in the same manner after enzymatic labeling of the
transcripts or virion RNAs with [5'-32P]pCp and RNA ligase,
purification on oligo(dT) cellulose, and digestion with RNase
T2. The HRsp and TotolOOO-derived virion RNAs gave
identical patterns, with only A being labeled, whereas the
transcripts from TotolOOO contained heterogeneous 3' ter-
mini (data not shown). This heterogeneity is presumably due
to alternative runoff of the SP6 polymerase at the 3' over-
hang generated by SstI cleavage (49). It is not known
whether the absence of heterogeneous 3'-terminal nucleo-
tides in TotolOOO virion RNAs results from elimination of
extra bases during replication or selective replication of
transcripts without extra nucleotides [possibly produced by
falloff of the SP6 polymerase in the poly(A) tract].
Proteins of virus derived from infectious transcripts. The
intracellular virus-specific proteins in cells infected with
HRsp, HR, TotolO, Toto5O, and TotolOOO are compared in
Fig. 3. The structural protein patterns are essentially identi-
cal, with PE2, El, and C clearly resolved. These proteins
have been shown to be immunoprecipitable with antisera
which are monospecific for each of the virion structural
proteins (data not shown). Of note is a strain variation
affecting the migration of PE2. PE2 of HRsp migrates
1 2 3 4 5 6 7 8 910 1 23 4 5 6
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FIG. 3. Structural and nonstructural proteins from parental and
in vitro-derived Sindbis strains. CEF monolayers infected with
Sindbis virus strains HR, TotolO, TotolOOO, HRsp, or Toto5O or
mock infected (lanes 1 to 6, respectively) were pulse-labeled with
L-[35S]methionine from 3 to 4 h post-infection. Lysates were run on
a 10% sodium dodecyl sulfate-polyacrylamide gel. Immunoprecipi-
tates of a Sindbis virus-infected lysate with antisera specific for
nsPl, nsP2, nsP3, and nsP4 were run in lanes 7 to 10, respectively.
The positions of structural protein precursors and nonstructural
proteins are indicated in the left and right margins, respectively. A
longer exposure of lanes 1 to 6, to intensify the bands of the
nonstructural proteins, is shown at the right of the figure.
slightly faster than PE2 from HR, and as shown in Fig. 3, the
PE2 of virus derived from TotolO and TotolOOO comigrates
with the HR PE2, whereas the PE2 of virus derived from
TotoSO migrates faster and comigrates with the HRsp PE2,
reflecting the source of the PE2 cDNA sequences.
The nonstructural proteins made by virus derived from
TotolO, TotoSO, and TotolOOO are indistinguishable from
those of parental Sindbis virus strains. Although only nsP2,
nsP3, and nsP4 can be identified in Fig. 3, the presence of
nsPl (which comigrates with PE2) and nsP4 (present in very
small quantities and migrating slightly faster than nsP3), as
well as that of nsP2, nsP3, and nsP34, has been verified by
immunoprecipitation (G. Li, unpublished data) with mono-
specific antisera to nsPl, nsP2, nsP3, and nsP4 (W. R. Hardy
and J. H. Strauss, manuscript in preparation).
Mapping of Toto5 defect. As mentioned above, the full-
length Sindbis virus cDNA clone, Toto5, did not yield
infectious RNA transcripts. We suspected that the Sindbis
virus sequences in TotoS contained a lethal mutation(s),
perhaps generated during cDNA cloning. This theory was
tested by the following strategy, which serves as an example
of how an infectious clone can be used to map a specific
phenotypic marker (in this case a lethal mutation). Individual
segments of TotoS, flanked by unique restriction sites, were
replaced with corresponding segments from independent
cDNA clones of Sindbis virus HRsp or HR. Of a number of
replacement clones tested, infectious in vitro transcripts
were obtained when the ClaI (nt 2713)-Spel (nt 5262) interval
of TotoS was replaced by that from HRsp cDNA or when the
ClaI (nt 2713)-AvrII (nt 4280) interval was replaced by that
from TotolOOO (Table 2). Infectious transcripts were not
obtained with replacement of other regions (results not
shown). Thus, Toto5 contains one or more lethal mutations
in the ClaI (nt 2713)-AvrII (nt 4280) region. Since this
interval does not contain additional unique restriction sites,
subclones of it were made, such that some of the sites in the
interval are now unique in the subclones. These sites were
then used for substituting smaller fragments of HRsp cDNA
into Toto5 sequences, after which the ClaI-AvrII fragment
was recloned into TotoS, resulting in TotoS derivatives
containing small sequence replacements. Of a number of
such derivatives tested, only the ClaI (nt 2713)-PvuII (nt
3103) segment rescued Toto5 (clone Toto5CP; Table 2).
Sequence analysis of this region showed that Toto5 has 2
base changes relative to TotoSO and TotolOOO, at positions
2824 (a C to T change leading to substitution of nsP2 Ala-382
of TotoSO by Val in TotoS) and 2992 (a T to C change leading
to substitution of nsP2 Leu-438 of TotoSO by Pro in TotoS).
The sequence of Sindbis virus (74) at position 2992, derived
from the same cDNA clone used to construct TotoS, is that
of the mutant and must be amended to a U. The two base
changes are on either sides of a NcoI site (nt 2976), which
was used to construct Toto5CN and Toto5NT, which have
single mutations at nucleotides 2824 and 2992, respectively.
Neither clone gave infectious in vitro transcripts (Table 2).
We conclude that TotoS contains two lethal point mutations.
Marker rescue of the temperature-sensitive mutation of ts2.
To demonstrate the utility of this approach for mapping ts
mutations, we replaced the capsid sequences of TotolOOO
with cDNA containing the ts2 mutation to produce a plasmid
called Toto ts2.1 (see Materials and Methods). ts2 is in
RNA' complementation group C. Sequence analysis of
cDNA clones derived from ts2 as well as from a tempera-
ture-insensitive revertant suggested that the ts2 phenotype
resulted from a C to U transition at position 701 of the 26S
mRNA, such that serine is substituted for proline at residue
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TABLE 2. Clones used to map mutations in TotoSa
Clone Toto5 sequence replacedb Rescue"
Toto5O ClaI 2713-SpeI 5262 +
Toto5CS ClaI 2713-Spel 5262 +
Toto5CA ClaI 2713-AvrII 4280 +
Toto5CP ClaI 2713-PvuII 3103 +
Toto5CN ClaI 2713-NcoI 2976
Toto5BN BgIII 2288-NcoI 2976 -
Toto5NT NcoI 2976-TthlllI 3912 -
Toto5PT PvuII 3103-TthlllI 3912 -
Toto5Bs BstXI 3441-BstXI 4175 -
TotoSTA TthlllI 3912-AvrII 4280 -
a See Materials and Methods for construction of these clones.
b Donor sequences were from HRsp cDNA, except that HR cDNA was
used for Toto5CS and Toto5CA.
c Transcripts of the clone were infectious (+) or noninfectious (-). Base
changes in Toto5 relative to TotoSO or TotolOOO are at nt 2824 and nt 2992.
HRsp 10 1000 ts2 ts2.l mock
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218 of the capsid protein (27). At the nonpermissive temper-
ature (40C), ts2 is defective in cotranslational cleavage of
the capsid protein from the nascent structural polyprotein
translated from 26S mRNA, resulting in the accumulation of
a 130-kDa polyprotein. Monolayers were transfected with
dilutions of RNA transcribed from Toto ts2.1 and incubated
at either 30°C (the permissive temperature) or 40°C (the
nonpermissive temperature). Plaques were observed at 30°C
but not at 40°C. The virus stock derived from these infec-
tious transcripts was clearly temperature sensitive, having
an efficiency of plating at 40°C/30°C of <2.7 x 10-4. We
examined the ability of this virus to complement repre-
sentative ts mutants from several other complementation
groups. The results in Table 3 show that the virus derived
from Toto ts2.1 complements all four of the RNA-
complementation groups but does not, as expected, comple-
ment ts2.
Figure 4 shows the Sindbis virus proteins extracted from
cells infected with HRsp, ts2, or virus derived from TotolO,
TotolOOO, or Toto ts2.1 and pulse-labeled at the permissive
and nonpermissive temperatures. The patterns of both ts2
and Toto ts2.1 are essentially similar to those of the parental
viruses at 30°C, but at 40°C, both viruses produce a promi-
nent species of about 130 kDa characteristic of ts2 and with
greatly diminished quantities of the cleaved structural pro-
teins. These polypeptides are virus specific, as demonstrated
by their absence from patterns of mock-infected monolayers
(Fig. 4) and by immunoprecipitation with antisera specific
for the structural proteins (data not shown). It is of interest
that while both TotolOOO and ts2, parents of Toto ts2.1,
produce large plaques at 30°C, the virus derived from Toto
ts2.1 has significantly smaller plaques. These different
plaque phenotypes of the ts2 mutation placed on different
genetic backgrounds raise the possibility that during selec-
tion or propagation of ts2, secondary mutations were se-
TABLE 3. Complementation analysis of virus derived
from Toto ts2.1
Complementation indexa with complementation group:
Virus C
A (ts24) B (tsll) F (ts6) G (tsl8)
ts2 Toto ts2.1
ts2 3 306 219 27 1 1
Toto ts2.1 7 212 77 32 1 1
a Complementation index at 40'C (73) defined as yield of the mixed infection
divided by the sum of the yields of the individual infections. Numbers are
rounded to the nearest integer.
FIG. 4. Proteins made by ts2- and Totots2.1-derived virus. Vi-
rus-infected (10, TotolO; 1000, TotolOOO; ts2, Sindbis virus ts2
mutant; ts2.1, Totots2.1) or mock-infected (mock) cells were incu-
bated at either 30 or 40°C and pulse-labeled with L-[35S]methionine
at the same temperatures from either 7 to 8 h (30°C) or 6 to 7 h (40°C)
postinfection. Lysates were run on a 10% sodium dodecyl sulfate-
polyacrylamide gel. The positions of C, PE2, El, and the protein
characteristic of the s2 mutant (ts2; ca. 130 kDa) are indicated in the
left margin.
lected on the basis of either larger plaque morphology or a
selective growth advantage or both.
In vitro mutagenesis of TotolOOO: formal evidence for
infectious in vitro transcripts. We inserted a 6-base-pair
TCTAGA XbaI linker in the RsaI site 14 nt 3' of the 26S
mRNA transcription start (56, 62). Transcription of this
clone, called TotolO02, produced infectious RNA. The virus
derived from TotolO02 retains the XbaI recognition se-
quence (Fig. 5), providing formal proof that viruses recov-
ered after transfection of cells are indeed derived from in
vitro transcripts. Using the assays described above, we
found that the virus is essentially wild type except for a slight
underproduction of 26S mRNA relative to 49S RNA.
DISCUSSION
We constructed full-length Sindbis virus HRsp and HRsp-
HR hybrid cDNA clones that can be transcribed in vitro to
produce infectious transcripts. Cells transfected with the
transcripts produce virions that are indistinguishable from
Sindbis virus and that retain strain-specific phenotypes re-
flecting their genetic origin. As has been found for other
viruses whose virion RNAs are normally capped (1, 16),
capping of in vitro-synthesized Sindbis virus transcripts
enhanced their infectivity. Most transcripts synthesized in
the presence of m7G(5')ppp(5')G are capped and include an
extra G residue at the 5' terminus. In addition, most of the
transcripts contain extra 3' terminal nucleotides. The spe-
cific infectivity (PFU/,ug of RNA) of the transcripts is about
10% of that of virion RNA. The RNA recovered from
Sindbis virions derived from the Toto clones appears to have
at least the same 3' termini as RNA from HR or HRsp virus.
Thus, if molecules containing these extra nucleotides are
infectious, the extra nucleotides are somehow selectively
deleted during virus replication. The eight extra G residues
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FIG. 5. Sequence of 26S mRNA 5' untranslated region of
TotolOOO and TotolOO2. Discrete primer extension products of
intracellular RNA from either TotolOOO- (1000) or TotolOO2- (1002)
infected cells corresponding to the 5' end of 26S RNA were isolated
and sequenced (see Materials and Methods). Dashes in the TotolOOO
ladder indicate the RsaI site used for insertion of the Xbal linker in
TotolO02. The linker sequence in the TotolO02 ladder is indicated,
i.e., 3'-AGATCT-5'.
at the 5' terminus of Toto3O led to inactive transcripts. Thus,
Sindbis virus seems to be more sensitive to extraneous
5'-terminal sequences than are certain other RNA viruses. In
the case of poliovirus cDNA clones transcribed with T7
RNA polymerase, the in vitro transcripts showed a 50-fold
increase in specific infectivity (to 5% of that of virion RNA;
81) when 58 extra nucleotides at the 5' terminus (leaving 2)
and 619 extra nucleotides at the 3' terminus (leaving 7) were
removed. In vitro transcripts of cDNA clones from another
picornavirus, human rhinovirus 14, are infectious even
though they contain 21 additional 5'-terminal nucleotides
(52). For black beetle virus, RNA 2 transcripts containing 20
extra 5' nucleotides are infectious, but in this case, their
removal does not increase specific infectivity (16). It is
possible that engineering Sindbis virus in vitro transcripts
with proper 5' and 3' termini may yield specific infectivities
closer to those of virion RNA.
Mapping of mutant phenotypes. The cDNA clones of
Sindbis virus can be used to define precisely the sequence
changes responsible for the phenotype of any Sindbis virus
variant by the strategy of exchanging segments of the
wild-type clone with cDNA of the variant and determining
the phenotype of the resulting clones (33, 38, 54, 59).
Complex phenotypes due to multiple sequence changes
(e.g., ts24; 65, 66) may be identified as such and dissected
into single changes whose individual contributions can be
determined. The mapping of the two lethal mutations of
Toto5 illustrates this approach. The strategy is feasible
whenever two strains of virus are closely related enough to
share usable restriction sites for exchanging segments. Al-
though Sindbis virus HRsp was derived from HR and
subsequently propagated separately, and although HRsp and
HR are known to differ at a number of nucleotide positions,
we have not found any differences in the restriction maps of
their cDNAs.
The infectious Sindbis virus cDNA clones may be used to
map a number of interesting phenotypes of Sindbis virus.
These phenotypes include mutants which affect virion mor-
phogenesis (72), host range (35), virulence in neonatal mice
(17, 53), enhanced neurovirulence in adult mice (26),
cytopathogenicity (84), actinomycin D resistance (3), im-
munodominant epitopes on the envelope glycoproteins, and
the ability to grow in low concentrations of methionine in
mosquito cells (20). We have also begun to map temperature-
sensitive mutations in each of the four RNA- complementa-
tion groups.
An important advantage of this approach is that any
mutation that is mapped is also preserved as a DNA clone,
with a correspondingly much lower mutation rate (32). The
mutation is also placed upon a known genetic background.
This placement makes possible the study of subtle effects of
the mutation and of the interaction between a mutation and
a particular genetic background and allows the facile con-
struction of viruses with multiply defined mutations. The
smaller plaque size of virus derived from Toto ts2.1 when
compared with the ts2 or the TotolOOO parents provide initial
evidence that the genetic background can be important.
Study of structure-function relationships via site-directed
mutagenesis. The cDNA clones may be mutagenized by any
of a number of methods to generate transcripts with novel
mutations, i.e., lethal, viable or conditional, which can be
studied both in vivo and in vitro (5, 7, 19, 28, 45, 51, 64). The
characterization of these mutants, in conjunction with the
traditionally derived mutants, will further our understanding
of the molecular biology of Sindbis virus. In addition to
TotolOO2 described here, we have constructed a set of
single- and multiple-codon insertion mutations of the
nonstructural protein genes and are characterizing the rep-
lication of the corresponding mutant viruses. The structural
proteins of Sindbis virus are better understood, and current
experiments include the targeted mutagenesis of the capsid
protein to define the amino acid residues responsible for its
autoprotease activity (27; C. Hahn and J. H. Strauss, per-
sonal communication).
Thus far, essentially all of the revertants of Sindbis virus ts
mutants derived by chemical mutagenesis (single-base sub-
stitutions) are true revertants resulting in restoration of the
wild-type sequence. The insertion-deletion or multiple-base-
change mutations that now can be introduced into the
Sindbis virus genome should be less easily revertable, thus
facilitating the selection of revertants with compensating
mutations elsewhere in the genome. Mapping and character-
ization of such second-site revertants should be extremely
valuable in elucidating functional interactions between the
nonstructural proteins and of the interactions of the
nonstructural proteins with cis-acting regulatory sequences.
We have obtained revertants from a number of codon-
insertion mutations in the nonstructural region and are
screening them for true second-site revertants. Similar ap-
proaches may be taken to study viral maturation to help
define the interactions of PE2 with El, of E2 with El, and of
capsid protein with the cytoplasmic extensions of the enve-
lope proteins or with 49S RNA.
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Other applications. The cDNA clones described here
consist of functional cDNA copies of the nonstructural and
structural protein genes of Sindbis virus. These sequence
modules may be inserted into existing gene expression
vectors to express large quantities of the corresponding
proteins for in vivo and in vitro studies, as well as to provide
trans complementation for the amplification and study of
lethal mutations. A vaccinia virus recombinant that ex-
presses the Sindbis virus structural proteins has been de-
scribed previously (61). The structural proteins have also
been expressed in yeast cells (85).
Finally, given the rapid and high level of expression of its
structural proteins, Sindbis virus can be used as a self-
replicating gene expression vector. We have shown that
Sindbis virus defective-interfering genomes can be used to
express the bacterial chloramphenicol acetyltransferase
(cat) gene (42). We show elsewhere that Sindbis virus, like
bromegrass mosaic virus (22) and tobacco mosaic virus (78),
can be used to express efficiently the cat gene (C. Xiong et
al., manuscript in preparation).
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